Immunocytochemical analysis of malignant melanoma of the nasal cavity and sinuses using tissue microarray [4]

Histopathology

Volumn 50, Issue 4, 2007, Pages 516-519

  Shashi Prasad, K R ^a   Jones, A S ^a   Birchall, M ^a   Krajacevic, J ^b   Helliwell, T R ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b WARRINGTON AND HALTON HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; MELAN A; MONOPHENOL MONOOXYGENASE; PROTEIN; PROTEIN P53; PROTEIN S 100; VIMENTIN;

ADULT; AGED; CANCER IMMUNOTHERAPY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LETTER; MELANOMA; NOSE CARCINOMA; PARANASAL SINUS CARCINOMA; PRIORITY JOURNAL; TISSUE MICROARRAY;

AGED; AGED, 80 AND OVER; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; MIDDLE AGED; NOSE NEOPLASMS; PARANASAL SINUSES; TISSUE ARRAY ANALYSIS;

EID: 33847255409     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02601.x     Document Type: Letter

References (13)

1. Nandapalan V, Roland NJ, Helliwell TR et al. Mucosal melanomas of the head and neck. Clin. Otolaryngol. 1998; 23; 107-116.
2. Kageshita T, Kimura T, Yoshii A et al. Antigenic profile of mucosal melanoma lesions. Int. J. Cancer 1994; 56; 370-374.
3. Henzen-Longmans SC, Meijer CJLM, Ruiter DJ et al. Diagnostic application of panels of antibodies in mucosal melanomas of the head and neck. Cancer 1988; 61; 702-711.
4. Fitzgibbons PL, Chaurushiya PS, Nichols PW, Chandrasoma PT, Martin SE. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas. Hum. Pathol. 1989; 20; 269-272.
5. Wick MR, Stanley SJ, Swanson PE. Immunohistochemical diagnosis of sinonasal melanoma, carcinoma and neuroblastoma with monoclonal antibodies HMB45 and anti-synaptophysin. Arch. Pathol. 1988; 112; 616-620.
6. Franquemont DW, Mills SE. Sinonasal melanoma. A clinicopathologic and immunohistochemical study of 14 cases. Am. J. Clin. Pathol. 1991; 96; 689-697.
7. Brandwein MS, Rothstein A, Lawson W, Bodian C, Urken ML. Sinonasal melanoma: a clinico-pathologic study of 25 cases and literature meta-analysis. Arch. Otolaryngol. 1997; 123; 290-296.
8. Patel SG, Prasad ML, Escrig M et al. Primary mucosal malignant melanoma of the head and neck. Head Neck 2002; 24; 247-257.
9. Banerjee SS, Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology 2000; 36; 387-402.
10. Zarbo RJ, Gown AM, Nagle RB, Visscher DW, Crissman JD. Anomalous cytokeratin expression in malignant melanoma. Mod. Pathol. 1990; 3; 494-501.
11. Feeley C, Theaker J. Epithelial markers in primary sinonasal melanoma. Histopathology 2004; 45; 96-98.
12. Komenaka I, Hoerig H, Kaufman HL. Immunotherapy for melanoma. Clin. Dermatol. 2004; 22; 251-256.
13. de Vries TJ, Trancikova D, Ruiter DJ, van Muijen GNP. High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanomas. Br. J. Cancer 1998; 78; 1156-1161.